With our partner Salesforce, unify sales, marketing and customer service. Accele your growth!
Simplified access to perineal rehabilitation and breastfeeding
Founded in 2017 at StrasbourgFizimed designed Emy Trainera connected probe allowing women to strengthen their perineum at homevia a fun mobile application. Unlike conventional solutions that require sessions in office, Emy Trainer democratizes perineal rehabilitation by making it accessible at home. The clinical trial led by Fizimed confirmed his Efficiency on improving perineal tonea key argument which allowed its adoption by physiotherapists and its reimbursement by German social security.
The company has also widened its portfolio with Emy PumpA Hand-free and nomadic breast pumpsdesigned to meet the needs of young mothers. Operating on battery and devoid of wires, it allows them to extract their milk without interrupting their activities, an alternative to traditional models deemed bulky.
An expanding market, but also under-exploited
The sector of femtech Remain underfalling with regard to existing needs. In Europe, perineal disorders concern Almost 100 million womenwhile 60 % of mothers abandon breastfeeding earlier than desiredfor lack of practical solutions. However, the market is experiencing strong growth, estimated to Over 75 billion euros by 2025.
Fizimed, already well established in Germany thanks to the integration ofEmy Trainer in the care path local, intends to capitalize on this proof of reimbursement To tackle markets French and Americanwhere health insurance could also play a key role in the democratization of its products. The objective: to have its devices recognized as tools for prevention in its own right, making it possible to avoid heavy and costly pathologies, such as organ descents or perineum surgeries.
A structuring to scaler
Fizimed’s ambition isimpose its devices as a medical standard in female health. The company is based on a network of partner health professionals and on a solid innovation ecosystem, in particular via Eit health, digital and quest for healthEuropean structures dedicated to supporting startups in Medtech.
To accelerate its deployment, Fizimed announces a 4 million euros with Autonomous patient fund (Bpifrance), Uniqa and UI Investment. This funding will allow Strengthen its presence in Germany, to intensify its development in the United States and to increase its partnerships with health professionals.
